(Hypertension. 1997;29:796-801.)
© 1997 American Heart Association, Inc.
Articles |
Role of the Lipoxygenase Pathway in Angiotensin II–Induced Vasoconstriction in the Human Placenta
the Institute of Endocrinology, Elias-Sourasky-Tel-Aviv Medical Center and Sackler Faculty of Medicine, Tel-Aviv (Israel) University.
We have previously shown that the vasopressor effect of angiotensin II (Ang II) is inhibited by lipoxygenase (LO) blockers. To elucidate the specific mechanism involved, we studied the relationship between the contractile effect of Ang II and LO products in a human placental preparation. In perfused placental cotyledons, Ang II (boluses of 1 to 10 µg) increased perfusion pressure and 12-hydroxyeicosatetraenoic acid (12-HETE) release. The LO blockers phenidone and n-propyl gallate reduced the maximal Ang II–induced increment in pressure from 26±3 to 16±3 and 18±4 mm Hg, respectively (P<.05 for both). Ang II alone (10 µg) increased 12-HETE release from 8.9±3.6 to 37.6±0.4 ng/min, and this rise was entirely blocked by both phenidone and n-propyl gallate. Pressure increase generated by an increase in flow rate had no effect on 12-HETE formation. In deendothelialized umbilical artery segments, Ang II (10–7 mol/L) increased 12-HETE formation by 47±5% (n=20). In cultured umbilical artery smooth muscle cells, Ang II increased 12-HETE formation from 48.1±7.2 to 75.1+15.3 ng/mg protein, and this effect was also blocked by the specific LO inhibitor baicalein (10-6 mol/L). These results provide evidence that the vasopressor effect of Ang II is functionally coupled to 12-LO activation, which apparently takes place in arterial smooth muscle cells.
Key Words: angiotensin II • 12-lipoxygenase • umbilical artery • placenta
This article has been cited by other articles:
 |
|
 |
|
  R. Limor, G. Weisinger, S. Gilad, E. Knoll, O. Sharon, A. Jaffe, F. Kohen, E. Berger, B. Lifschizt-Mercer, and N. Stern A Novel Form of Platelet-Type 12-Lipoxygenase mRNA in Human Vascular Smooth Muscle Cells Hypertension, October 1, 2001; 38(4): 864 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Muthalif, N. A. Karzoun, L. Gaber, Z. Khandekar, I. F. Benter, A. E. Saeed, J.-H. Parmentier, A. Estes, and K. U. Malik Angiotensin II-Induced Hypertension : Contribution of Ras GTPase/Mitogen-Activated Protein Kinase and Cytochrome P450 Metabolites Hypertension, October 1, 2000; 36(4): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Stanke-Labesque, P. Devillier, P. Bedouch, J. L. Cracowski, O. Chavanon, and G. Bessard Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition Cardiovasc Res, August 1, 2000; 47(2): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Frisbee, J. R. Falck, and J. H. Lombard Contribution of cytochrome P-450 omega -hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1517 - H1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Rosenthal, E. D. Albrecht, and G. J. Pepe Developmental Maturation of Baboon Placental Trophoblast: Expression of Messenger Ribonucleic Acid and Protein Levels of Cytosolic and Secretory Phospholipases A2 J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2861 - 2867. [Abstract] [Full Text]
|
|
|
|
|
|
D. Somjen, F. Kohen, A. Jaffe, Y. Amir-Zaltsman, E. Knoll, and N. Stern Effects of Gonadal Steroids and Their Antagonists on DNA Synthesis in Human Vascular Cells Hypertension, July 1, 1998; 32(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takizawa, A. DelliPizzi, and A. Nasjletti Prostaglandin I2 Contributes to the Vasodepressor Effect of Baicalein in Hypertensive Rats Hypertension, March 1, 1998; 31(3): 866 - 871. [Abstract] [Full Text] [PDF]
|
|